Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and Section Editors for this issue.
EDITOR IN CHIEF
Barry M. Brenner
Barry M. Brenner is Director Emeritus of the Renal Division, Brigham & Women's Hospital and Harvard Medical School in Boston, USA. He earned a B.S. in biology at the Long Island University, USA, in 1958, and his M.D. from the University of Pittsburgh School of Medicine, USA in 1962. Dr Brenner completed his internship and residency at the Bronx Municipal Hospital Center, Albert Einstein College of Medicine, USA in 1966. He continued his career in research positions at the National Heart Institute, and the University of California, San Francisco, USA before arriving at Harvard in 1976. Dr Brenner has held various positions at the Brigham and Women's Hospital including: Director, Laboratory of Kidney and Electrolyte Physiology, Senior Physician and Director. His basic and clinical research focuses on mechanisms of glomerular function in health and disease.
Dr Brenner is a member of the American Society for Clinical Investigation (Councillor from 1980 to 1982, Vice-President from 1983 to 1984), the American Society of Nephrology (Councillor from 1980 to 1986, President from 1986 to 1987). Furthermore, he is a member of the American Society of Hypertension (Organizing Committee from 1985 to 1987, Executive Committee from 1986 to 1995, President from 1994 to 1995), International Society of Nephrology (Councillor from 1987 to 1998, Co-Chairman, Commission for Global Advancement of Nephrology from 1994 to 1999), American Association of Physicians (Councillor, from 1995 to 1999); and the American Association for the Advancement of Science (Chair, Section on Medical Sciences from 1995 to 1998).
Dr Brenner has received numerous awards and accolades, including his most recent honors: Best Doctors in America, Second Edition (1997); Fellow, Royal College of Physicians, London (1998); Jean Hamburger Award (1999) and Amgen Prize (2003), International Society of Nephrology; and the Homer Smith (1984) and John P. Peters (2000) Awards, American Society of Nephrology. Dr Brenner has held 25 editorial board appointments, has published more than 600 scientific articles and 45 books and has participated in over 300 lectures and/or professorships. He has since received honorary degrees from Harvard University (A.M., 1977), Long Island University (D.Sc.,1987), Universite’ de Paris, France, Pierre et Marie Curie (D.Med. Sci., 1992), France, and Universidad Complutense de Madrid (M.D. 2002), Spain. Dr Brenner was elected to the American Academy of Arts and Sciences in 2003.
Dr Mark Cooper is the inaugural Head of the Department of Diabetes, Central Clinical School, Monash University, Australia. He was previously the Chief Scientific Officer of the Baker IDI Heart & Diabetes Institute, Australia, as well as the Director of the Juvenile Diabetes Research Foundation Centre (JDRF) for Diabetes Complications. He is a trained endocrinologist with an appointment at the co-located Alfred Hospital, Australia. Dr Cooper studied medicine at the University of Melbourne, Australia, and then completed his physicians training as well as his PhD under Dr George Jerums and Professor Austin Doyle in the Austin Hospital, University of Melbourne. Dr Cooper has successfully competed for a large number of peer-reviewed grants over the last 15 years from a range of organizations including not only JDRF but also the National Health and Medical Research Council of Australia, National Institutes of Health, National Heart Foundation of Australia, Diabetes Australia, and Kidney Health Australia.
In 1999, Dr Cooper was awarded the Eric Susman prize from the Royal Australasian College of Physicians for his research in the field of renal and vascular complications of diabetes. The same year, he was awarded a Centre Grant from JDRF which was subsequently renewed in 2003. In 2005, he was awarded the Australian Diabetes Society (ADS) Kellion Award for outstanding contributions to diabetes research in Australia. He is also a previous recipient of a scholar's award from the JDRF. This work was further supported by a five-year Australia Fellowship awarded by NHMRC in 2009. Dr Cooper is currently Co-Chair of the JDRF Medical Science Review Committee (Complications Panel). He is regularly invited to international meetings and has over 500 peer-reviewed publications. Dr Cooper was the 2016 recipient of the Claude Bernard Award from the European Association for the Study of Diabetes and in 2017 the Edwin Bierman Award from the American Diabetes Association. He received an Order of Australia (Officer) in 2017.
Professor Merlin Thomas is a physician scientist at the Department of Diabetes in Monash University, Australia, where he is program leader and head of the Biochemistry of Diabetic Complications laboratory.
Professor Thomas is a translational scientist and academic leader in the field of diabetic kidney disease. He has a productive track record of high quality research, with over 280 career publications. His translational research spans basic biochemistry and biology to epidemiology and clinical trials. He is also a sought-after speaker, teacher and best-selling author.
Dr Thomas trained in medicine at the University of Otago, New Zealand and qualified with distinction in 1992. In 1998 he was named Royal Australasian College of Physicians Young Investigator of the Year. In 2001, he was awarded a Dora Lush Biomedical research scholarship to study for a PhD at the University of Melbourne and was subsequently awarded the Victorian Premiers Award for Medical Research. Upon completion of his PhD in 2004, he took up the Don and Lorraine Jacquot Fellowship to continue his research into advanced glycation end-products. In 2006, he was awarded the inaugural Partnership Award: Diabetes Australia/NHMRC Career Development Award and established his Biochemistry of Diabetic Complications laboratory at the Baker Heart Research Institute. In 2016, he became head of the Diabetes Program at the Baker IDI. In 2017, he moved his laboratory to the newly established Department of Diabetes at the Central Clinical School of Monash University, where he was appointed a program leader and academic professor in the department.
His work in the field of diabetic complications is internationally recognised, and he has been invited to speak at international meetings including the American Society of Nephrology, Keystone Symposia, World Congress of Diabetes, and the International Society of Nephrology. His work has also received a number of awards including the 20th Servier lectureship and the Finska Läkaresällskapet prize. In 2017, he was awarded the ANZSN TJ Neale Award, their highest award for scientific achievement.